Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)

National Institutes of Health

Federal funding opportunity PAR-24-279 published by National Institutes of Health. Review the official synopsis for eligibility, award terms, and application requirements.